25 XP   0   0   10

Augmedix Inc
Buy, Hold or Sell?

Let's analyse Augmedix together

PenkeI guess you are interested in Augmedix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Augmedix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Augmedix Inc

I send you an email if I find something interesting about Augmedix Inc.

Quick analysis of Augmedix (30 sec.)










What can you expect buying and holding a share of Augmedix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.34
Expected worth in 1 year
$0.64
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
$0.31
Return On Investment
38.0%

For what price can you sell your share?

Current Price per Share
$0.80
Expected price per share
$0.73 - $1.34
How sure are you?
50%

1. Valuation of Augmedix (5 min.)




Live pricePrice per Share (EOD)

$0.80

Intrinsic Value Per Share

$-5.44 - $-6.38

Total Value Per Share

$-5.10 - $-6.04

2. Growth of Augmedix (5 min.)




Is Augmedix growing?

Current yearPrevious yearGrowGrow %
How rich?$17.7m$5.1m$6.3m55.2%

How much money is Augmedix making?

Current yearPrevious yearGrowGrow %
Making money-$5.1m-$6.4m$1.3m25.9%
Net Profit Margin-42.0%-80.1%--

How much money comes from the company's main activities?

3. Financial Health of Augmedix (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#69 / 117

Most Revenue
#63 / 117

Most Profit
#81 / 117

What can you expect buying and holding a share of Augmedix? (5 min.)

Welcome investor! Augmedix's management wants to use your money to grow the business. In return you get a share of Augmedix.

What can you expect buying and holding a share of Augmedix?

First you should know what it really means to hold a share of Augmedix. And how you can make/lose money.

Speculation

The Price per Share of Augmedix is $0.8035. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Augmedix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Augmedix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.34. Based on the TTM, the Book Value Change Per Share is $0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Augmedix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.12-15.2%-0.10-12.7%-0.12-15.1%-0.10-12.6%-0.10-11.9%
Usd Book Value Change Per Share-0.14-17.5%0.089.5%-0.09-10.6%0.022.5%0.022.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.14-17.5%0.089.5%-0.09-10.6%0.022.5%0.022.3%
Usd Price Per Share4.09-4.98-1.64-2.86-2.70-
Price to Earnings Ratio-8.35--12.58--3.42--7.50--7.08-
Price-to-Total Gains Ratio-29.08--0.13--14.32--25.46--25.46-
Price to Book Ratio12.21-106.78-32.28-13.37-12.63-
Price-to-Total Gains Ratio-29.08--0.13--14.32--25.46--25.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8035
Number of shares1244
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.080.02
Usd Total Gains Per Share0.080.02
Gains per Quarter (1244 shares)94.9024.58
Gains per Year (1244 shares)379.6098.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1038037009888
207597500197186
30113911300295284
40151815100393382
50189818900492480
60227822700590578
70265726500688676
80303730300787774
90341634100885872
100379637900983970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.01.00.0%0.017.01.00.0%
Book Value Change Per Share2.02.00.050.0%3.08.01.025.0%4.011.02.023.5%4.012.02.022.2%4.012.02.022.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share2.02.00.050.0%3.08.01.025.0%4.011.02.023.5%4.012.02.022.2%4.012.02.022.2%

Fundamentals of Augmedix

About Augmedix Inc

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Fundamental data was last updated by Penke on 2024-06-07 04:56:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Augmedix Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Augmedix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare¬†Augmedix to the¬†Health Information Services industry mean.
  • A Net Profit Margin of -48.2%¬†means that¬†$-0.48 for each $1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Augmedix Inc:

  • The MRQ is -48.2%. The company is making a huge loss. -2
  • The TTM is -42.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-48.2%TTM-42.0%-6.3%
TTM-42.0%YOY-80.1%+38.2%
TTM-42.0%5Y-75.2%+33.2%
5Y-75.2%10Y-71.0%-4.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-48.2%-19.1%-29.1%
TTM-42.0%-21.8%-20.2%
YOY-80.1%-28.5%-51.6%
5Y-75.2%-33.6%-41.6%
10Y-71.0%-40.4%-30.6%
1.1.2. Return on Assets

Shows how efficient Augmedix is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Augmedix to the¬†Health Information Services industry mean.
  • -10.9% Return on Assets means that¬†Augmedix generated¬†$-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Augmedix Inc:

  • The MRQ is -10.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-10.0%-0.9%
TTM-10.0%YOY-17.6%+7.6%
TTM-10.0%5Y-20,898.1%+20,888.2%
5Y-20,898.1%10Y-19,737.1%-1,161.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%-5.3%-5.6%
TTM-10.0%-4.4%-5.6%
YOY-17.6%-4.9%-12.7%
5Y-20,898.1%-5.3%-20,892.8%
10Y-19,737.1%-5.7%-19,731.4%
1.1.3. Return on Equity

Shows how efficient Augmedix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Augmedix to the¬†Health Information Services industry mean.
  • -36.6% Return on Equity means Augmedix generated $-0.37¬†for each¬†$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Augmedix Inc:

  • The MRQ is -36.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -195.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.6%TTM-195.6%+159.0%
TTM-195.6%YOY-234.9%+39.3%
TTM-195.6%5Y-111.7%-83.9%
5Y-111.7%10Y-105.5%-6.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.6%-3.3%-33.3%
TTM-195.6%-5.6%-190.0%
YOY-234.9%-8.2%-226.7%
5Y-111.7%-8.7%-103.0%
10Y-105.5%-8.6%-96.9%

1.2. Operating Efficiency of Augmedix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Augmedix is operating .

  • Measures how much profit Augmedix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Augmedix to the¬†Health Information Services industry mean.
  • An Operating Margin of -47.5%¬†means the company generated $-0.48 ¬†for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Augmedix Inc:

  • The MRQ is -47.5%. The company is operating very inefficient. -2
  • The TTM is -42.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-47.5%TTM-42.8%-4.7%
TTM-42.8%YOY-70.7%+27.9%
TTM-42.8%5Y-71.0%+28.2%
5Y-71.0%10Y-67.0%-3.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-47.5%-23.1%-24.4%
TTM-42.8%-12.8%-30.0%
YOY-70.7%-23.4%-47.3%
5Y-71.0%-17.8%-53.2%
10Y-67.0%-24.5%-42.5%
1.2.2. Operating Ratio

Measures how efficient Augmedix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Health Information Services industry mean).
  • An Operation Ratio of 1.48 means that the operating costs are $1.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Augmedix Inc:

  • The MRQ is 1.475. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.412. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.475TTM1.412+0.063
TTM1.412YOY1.825-0.412
TTM1.4125Y1.724-0.312
5Y1.72410Y1.629+0.096
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4751.416+0.059
TTM1.4121.378+0.034
YOY1.8251.393+0.432
5Y1.7241.297+0.427
10Y1.6291.297+0.332

1.3. Liquidity of Augmedix Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Augmedix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Health Information Services industry mean).
  • A Current Ratio of 2.04¬†means the company has $2.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Augmedix Inc:

  • The MRQ is 2.038. The company is able to pay all its short-term debts. +1
  • The TTM is 2.836. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.038TTM2.836-0.799
TTM2.836YOY3.404-0.567
TTM2.8365Y2.704+0.132
5Y2.70410Y2.558+0.146
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0381.719+0.319
TTM2.8361.686+1.150
YOY3.4042.110+1.294
5Y2.7042.691+0.013
10Y2.5582.631-0.073
1.3.2. Quick Ratio

Measures if Augmedix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Augmedix to the¬†Health Information Services industry mean.
  • A Quick Ratio of 1.93¬†means the company can pay off $1.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Augmedix Inc:

  • The MRQ is 1.933. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.790. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.933TTM2.790-0.857
TTM2.790YOY3.103-0.313
TTM2.7905Y5.849-3.059
5Y5.84910Y5.529+0.321
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9331.127+0.806
TTM2.7901.135+1.655
YOY3.1031.627+1.476
5Y5.8492.204+3.645
10Y5.5292.156+3.373

1.4. Solvency of Augmedix Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Augmedix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Augmedix to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.70¬†means that Augmedix assets are¬†financed with 70.1% credit (debt) and the remaining percentage (100% - 70.1%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Augmedix Inc:

  • The MRQ is 0.701. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.811. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.701TTM0.811-0.109
TTM0.811YOY0.866-0.055
TTM0.8115Y5.329-4.518
5Y5.32910Y5.730-0.401
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7010.380+0.321
TTM0.8110.396+0.415
YOY0.8660.396+0.470
5Y5.3290.415+4.914
10Y5.7300.441+5.289
1.4.2. Debt to Equity Ratio

Measures if Augmedix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Augmedix to the¬†Health Information Services industry mean.
  • A Debt to Equity ratio of 235.0% means that company has $2.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Augmedix Inc:

  • The MRQ is 2.350. The company is just not able to pay all its debts with equity.
  • The TTM is 17.208. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.350TTM17.208-14.859
TTM17.208YOY12.821+4.387
TTM17.2085Y7.694+9.515
5Y7.69410Y7.266+0.427
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3500.564+1.786
TTM17.2080.599+16.609
YOY12.8210.630+12.191
5Y7.6940.718+6.976
10Y7.2660.673+6.593

2. Market Valuation of Augmedix Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Augmedix generates.

  • Above 15 is considered overpriced but¬†always compare¬†Augmedix to the¬†Health Information Services industry mean.
  • A PE ratio of -8.35 means the investor is paying $-8.35¬†for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Augmedix Inc:

  • The EOD is -1.640. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.348. Based on the earnings, the company is expensive. -2
  • The TTM is -12.579. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.640MRQ-8.348+6.708
MRQ-8.348TTM-12.579+4.231
TTM-12.579YOY-3.417-9.162
TTM-12.5795Y-7.502-5.078
5Y-7.50210Y-7.085-0.417
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.640-1.519-0.121
MRQ-8.348-2.141-6.207
TTM-12.579-1.908-10.671
YOY-3.417-3.057-0.360
5Y-7.502-5.741-1.761
10Y-7.085-5.205-1.880
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Augmedix Inc:

  • The EOD is -1.211. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.162. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.618. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.211MRQ-6.162+4.952
MRQ-6.162TTM-17.618+11.455
TTM-17.618YOY-4.481-13.137
TTM-17.6185Y-8.965-8.652
5Y-8.96510Y-8.467-0.498
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.211-1.625+0.414
MRQ-6.162-2.360-3.802
TTM-17.618-2.015-15.603
YOY-4.481-5.267+0.786
5Y-8.965-5.174-3.791
10Y-8.467-3.022-5.445
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Augmedix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Health Information Services industry mean).
  • A PB ratio of 12.21 means the investor is paying $12.21¬†for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Augmedix Inc:

  • The EOD is 2.398. Based on the equity, the company is underpriced. +1
  • The MRQ is 12.206. Based on the equity, the company is expensive. -2
  • The TTM is 106.781. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.398MRQ12.206-9.808
MRQ12.206TTM106.781-94.575
TTM106.781YOY32.282+74.499
TTM106.7815Y13.373+93.408
5Y13.37310Y12.630+0.743
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD2.3981.502+0.896
MRQ12.2061.722+10.484
TTM106.7811.946+104.835
YOY32.2822.566+29.716
5Y13.3734.466+8.907
10Y12.6304.567+8.063
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Augmedix Inc.

3.1. Institutions holding Augmedix Inc

Institutions are holding 87.088% of the shares of Augmedix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Redmile Group, LLC33.45132.459163803277500004.7984
2024-03-31Samjo Management LLC8.08535.69583959200100220033.8925
2024-03-31Perkins Capital Management Inc2.9784.97321458268-6300-0.4302
2024-03-31Vanguard Group Inc2.65980.0001130242417953415.9886
2024-03-31Balyasny Asset Management LLC2.41160.00841180928682924137.1322
2024-03-31Parkman Healthcare Partners LLC2.17720.5351066109502954.9512
2024-03-31Millennium Management LLC2.1340.00181044968649054163.9381
2024-03-31Rhenman Partners Asset Management AB1.63370.31018000008000000
2024-03-31G2 Investment Partners Management LLC1.28430.681628886288864.8143
2024-03-31Essex Investment Management Company, LLC1.08030.42752898512545731.09
2024-03-31Ardsley Advisory Partners1.07210.308552500000
2024-03-31American Financial Group Inc1.02110.768450000000
2024-03-31Hood River Capital Management LLC1.00110.044749023821633978.985
2024-03-31Schonfeld Strategic Advisors LLC0.95760.0128468897376997410.2252
2024-03-31Geode Capital Management, LLC0.87970.00024307656915019.1225
2024-03-31Kennedy Capital Management Inc0.75720.0312370806-28564-7.1523
2024-03-31Next Century Growth Investors LLC0.73990.128736230716830.4667
2024-03-31Marshall Wace Asset Management Ltd0.69120.0021338445294720674.0309
2024-03-31Millrace Asset Group, Inc0.60891.22492981479506046.8075
2024-03-31Susquehanna International Group, LLP0.53750.000226318710132262.5966
Total 66.161817.613132397887+5388757+16.6%

3.2. Funds holding Augmedix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Rhenman Healthcare Equity L/S RC2 SEK1.63370.3699800000700000700
2024-04-30Vanguard Total Stock Mkt Idx Inv1.52820.0001748321549497.9249
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr1.25370.0017613928548829.8171
2024-03-31Ancora/Thelen Small Mid Cap Core0.83980.3927411210208320102.6763
2024-03-31Kennedy Extended Small Cap0.75720.0959370806-28564-7.1523
2024-04-30Fidelity Extended Market Index0.4840.0018236988-2148-0.8982
2024-04-30Russell Inv US Small Cap Equity E0.47240.07123131400
2024-03-31Ancora/Thelen Small-Mid Cap I0.34970.39517125088050105.8293
2024-04-30Russell Inv Tax-Managed US Mid&Sm Cap S0.31650.02681549711549710
2024-03-31WPG Partners Micro Cap Opportunities0.28271.33481384085437264.7008
2024-03-31Pleiades Small Cap Equity A0.27170.0537133053-43857-24.7906
2024-03-31Empower Small Cap Value/Kennedy SP0.26030.095912746500
2024-03-311290 Essex Small Cap Growth I0.22830.767411176900
2024-03-31Next Century Growth Micro Cap Growth0.19930.33199760600
2024-05-30Themes Generative Artificial Int ETF0.17580.44048606600
2024-04-30Russell Inv Small Cap Fund B0.16590.0468123500
2024-03-31BlackRock Extended Equity Market K0.16560.002381109290.0358
2024-02-29Hood River Small/Mid Cap Gr CITFounder's0.16050.396978579-744-0.9379
2024-03-31Hood River Small/Mid-Cap Growth0.16050.354578579-744-0.9379
2024-04-30Fidelity Total Market Index0.15530.00027604900
Total 9.86115.17894828706+1239516+25.7%

3.3. Insider Transactions

Insiders are holding 6.296% of the shares of Augmedix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-05-15Emmanuel KrakarisSELL35281.19
2024-05-15Ian ShakilSELL13871.19
2024-05-15Paul GinocchioSELL23541.19
2024-05-15Saurav ChatterjeeSELL17671.19
2024-04-15Ian ShakilSELL5003.8
2024-04-11Ian ShakilSELL247783.93
2024-04-08Ian ShakilSELL377803.97
2024-04-05Ian ShakilSELL513874.03
2024-04-03Ian ShakilSELL459064.11
2024-04-01Ian ShakilSELL589783.91
2024-03-28Ian ShakilSELL319944.06
2023-11-22Paul GinocchioBUY100004.85

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Augmedix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1410.076-284%-0.085-39%0.020-812%0.019-856%
Book Value Per Share--0.3350.227+48%0.105+219%0.116+188%0.110+205%
Current Ratio--2.0382.836-28%3.404-40%2.704-25%2.558-20%
Debt To Asset Ratio--0.7010.811-13%0.866-19%5.329-87%5.730-88%
Debt To Equity Ratio--2.35017.208-86%12.821-82%7.694-69%7.266-68%
Dividend Per Share----0%-0%-0%-0%
Eps---0.122-0.102-17%-0.121-1%-0.101-18%-0.095-22%
Free Cash Flow Per Share---0.166-0.104-38%-0.092-45%-0.093-44%-0.087-47%
Free Cash Flow To Equity Per Share---0.1650.092-279%-0.098-41%0.029-666%0.027-699%
Gross Profit Margin--1.5481.576-2%1.275+21%1.397+11%1.319+17%
Intrinsic Value_10Y_max---6.380--------
Intrinsic Value_10Y_min---5.435--------
Intrinsic Value_1Y_max---0.423--------
Intrinsic Value_1Y_min---0.415--------
Intrinsic Value_3Y_max---1.435--------
Intrinsic Value_3Y_min---1.366--------
Intrinsic Value_5Y_max---2.646--------
Intrinsic Value_5Y_min---2.442--------
Market Cap39345546.950-452%217009948.030247875411.445-12%80184608.750+171%141107843.752+54%133268519.099+63%
Net Profit Margin---0.482-0.420-13%-0.801+66%-0.752+56%-0.710+47%
Operating Margin---0.475-0.428-10%-0.707+49%-0.710+49%-0.670+41%
Operating Ratio--1.4751.412+4%1.825-19%1.724-14%1.629-9%
Pb Ratio2.398-409%12.206106.781-89%32.282-62%13.373-9%12.630-3%
Pe Ratio-1.640+80%-8.348-12.579+51%-3.417-59%-7.502-10%-7.085-15%
Price Per Share0.804-409%4.0904.975-18%1.638+150%2.861+43%2.702+51%
Price To Free Cash Flow Ratio-1.211+80%-6.162-17.618+186%-4.481-27%-8.965+45%-8.467+37%
Price To Total Gains Ratio-5.713+80%-29.079-0.126-100%-14.318-51%-25.459-12%-25.459-12%
Quick Ratio--1.9332.790-31%3.103-38%5.849-67%5.529-65%
Return On Assets---0.109-0.100-9%-0.176+61%-208.981+191408%-197.371+180768%
Return On Equity---0.366-1.956+435%-2.349+543%-1.117+206%-1.055+189%
Total Gains Per Share---0.1410.076-284%-0.085-39%0.020-812%0.019-856%
Usd Book Value--17779000.00011455750.000+55%5137500.000+246%5780540.353+208%5457038.667+226%
Usd Book Value Change Per Share---0.1410.076-284%-0.085-39%0.020-812%0.019-856%
Usd Book Value Per Share--0.3350.227+48%0.105+219%0.116+188%0.110+205%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.122-0.102-17%-0.121-1%-0.101-18%-0.095-22%
Usd Free Cash Flow---8804000.000-5239000.000-40%-4488750.000-49%-4574823.529-48%-4321074.778-51%
Usd Free Cash Flow Per Share---0.166-0.104-38%-0.092-45%-0.093-44%-0.087-47%
Usd Free Cash Flow To Equity Per Share---0.1650.092-279%-0.098-41%0.029-666%0.027-699%
Usd Market Cap39345546.950-452%217009948.030247875411.445-12%80184608.750+171%141107843.752+54%133268519.099+63%
Usd Price Per Share0.804-409%4.0904.975-18%1.638+150%2.861+43%2.702+51%
Usd Profit---6499000.000-5107500.000-21%-6430500.000-1%-5031915.294-23%-4752364.444-27%
Usd Revenue--13471000.00012174500.000+11%8174750.000+65%7472365.706+80%7057234.278+91%
Usd Total Gains Per Share---0.1410.076-284%-0.085-39%0.020-812%0.019-856%
 EOD+3 -5MRQTTM+9 -25YOY+18 -165Y+17 -1710Y+17 -17

4.2. Fundamental Score

Let's check the fundamental score of Augmedix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.640
Price to Book Ratio (EOD)Between0-12.398
Net Profit Margin (MRQ)Greater than0-0.482
Operating Margin (MRQ)Greater than0-0.475
Quick Ratio (MRQ)Greater than11.933
Current Ratio (MRQ)Greater than12.038
Debt to Asset Ratio (MRQ)Less than10.701
Debt to Equity Ratio (MRQ)Less than12.350
Return on Equity (MRQ)Greater than0.15-0.366
Return on Assets (MRQ)Greater than0.05-0.109
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Augmedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.328
Ma 20Greater thanMa 500.897
Ma 50Greater thanMa 1001.865
Ma 100Greater thanMa 2003.010
OpenGreater thanClose0.790
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets59,556
Total Liabilities41,777
Total Stockholder Equity17,779
 As reported
Total Liabilities 41,777
Total Stockholder Equity+ 17,779
Total Assets = 59,556

Assets

Total Assets59,556
Total Current Assets49,973
Long-term Assets9,583
Total Current Assets
Cash And Cash Equivalents 37,426
Net Receivables 9,979
Other Current Assets 2,568
Total Current Assets  (as reported)49,973
Total Current Assets  (calculated)49,973
+/-0
Long-term Assets
Property Plant Equipment 8,515
Long-term Assets Other 859
Long-term Assets  (as reported)9,583
Long-term Assets  (calculated)9,374
+/- 209

Liabilities & Shareholders' Equity

Total Current Liabilities24,526
Long-term Liabilities17,251
Total Stockholder Equity17,779
Total Current Liabilities
Short-term Debt 8,987
Short Long Term Debt 7,500
Accounts payable 1,245
Other Current Liabilities 5,280
Total Current Liabilities  (as reported)24,526
Total Current Liabilities  (calculated)23,012
+/- 1,514
Long-term Liabilities
Long term Debt 12,952
Capital Lease Obligations 5,238
Long-term Liabilities Other 548
Long-term Liabilities  (as reported)17,251
Long-term Liabilities  (calculated)18,738
+/- 1,487
Total Stockholder Equity
Common Stock5
Retained Earnings -151,461
Accumulated Other Comprehensive Income -906
Other Stockholders Equity 170,141
Total Stockholder Equity (as reported)17,779
Total Stockholder Equity (calculated)17,779
+/-0
Other
Capital Stock5
Cash and Short Term Investments 37,426
Common Stock Shares Outstanding 53,059
Current Deferred Revenue9,014
Liabilities and Stockholders Equity 59,556
Net Debt -11,736
Net Invested Capital 38,231
Net Working Capital 25,447
Property Plant and Equipment Gross 11,882
Short Long Term Debt Total 25,690



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
4
7
0
0
0
2
4
27,935
25,423
22,950
19,110
51,683
46,274
40,563
37,149
33,641
33,641
43,848
40,833
66,712
59,556
59,55666,71240,83343,84833,64133,64137,14940,56346,27451,68319,11022,95025,42327,9354200074
   > Total Current Assets 
4
7
0
0
8,958
2
4
26,770
24,092
21,710
17,654
48,765
41,193
35,475
32,050
29,550
28,342
34,693
31,732
56,823
49,973
49,97356,82331,73234,69328,34229,55032,05035,47541,19348,76517,65421,71024,09226,770428,9580074
       Cash And Cash Equivalents 
4
7
0
0
0
2
4
20,762
19,052
16,353
10,786
41,587
36,652
30,778
26,997
21,988
21,988
25,260
22,286
46,342
37,426
37,42646,34222,28625,26021,98821,98826,99730,77836,65241,58710,78616,35319,05220,7624200074
       Net Receivables 
0
0
0
0
2,992
2,992
2,562
2,693
3,880
3,775
5,542
7,178
4,209
4,697
5,053
6,354
6,354
9,433
9,446
8,572
9,979
9,9798,5729,4469,4336,3546,3545,0534,6974,2097,1785,5423,7753,8802,6932,5622,9922,9920000
       Other Current Assets 
0
0
0
0
2,000
2,000
2,000
1,104
1,084
1,457
1,201
1,868
1,805
1,729
1,656
125
1,945
2,086
2,031
1,909
2,568
2,5681,9092,0312,0861,9451251,6561,7291,8051,8681,2011,4571,0841,1042,0002,0002,0000000
   > Long-term Assets 
0
0
0
0
0
0
0
1,165
1,331
1,240
1,456
2,918
5,081
5,088
5,099
5,299
5,299
9,155
9,101
9,889
9,583
9,5839,8899,1019,1555,2995,2995,0995,0885,0812,9181,4561,2401,3311,1650000000
       Property Plant Equipment 
0
0
0
0
1,094
1,094
995
992
948
964
972
982
3,333
3,070
3,041
3,140
3,140
6,237
6,290
8,959
8,515
8,5158,9596,2906,2373,1403,1403,0413,0703,3339829729649489929951,0941,0940000
       Other Assets 
0
0
0
0
173
173
1,108
173
383
276
484
2,918
275
5,088
5,099
951
0
9,155
0
0
0
0009,15509515,0995,0882752,9184842763831731,1081731730000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
208
0
0
0
0
0
0
0
0
0
0
00000000002080000000000
> Total Liabilities 
46
59
60
69
0
91
111
24,811
26,416
27,642
26,274
27,999
28,098
29,396
30,698
32,175
32,175
39,859
40,099
43,391
41,777
41,77743,39140,09939,85932,17532,17530,69829,39628,09827,99926,27427,64226,41624,81111191069605946
   > Total Current Liabilities 
46
59
60
69
13,464
91
111
16,473
9,788
10,679
11,294
7,603
6,662
7,447
7,805
19,314
8,817
9,462
9,809
23,618
24,526
24,52623,6189,8099,4628,81719,3147,8057,4476,6627,60311,29410,6799,78816,4731119113,46469605946
       Short-term Debt 
0
0
0
0
0
0
0
6,613
51
52
51
1,500
3,853
860
2,741
0
4,622
6,471
8,934
6,494
8,987
8,9876,4948,9346,4714,62202,7418603,8531,5005152516,6130000000
       Short Long Term Debt 
0
0
0
0
0
0
0
6,613
0
0
0
1,500
3,000
0
1,875
3,750
2,500
5,000
7,500
5,000
7,500
7,5005,0007,5005,0002,5003,7501,87503,0001,5000006,6130000000
       Accounts payable 
0
0
0
0
590
590
13
259
1,004
1,221
1,370
1,365
1,401
1,584
1,417
1,563
1,563
1,604
1,816
721
1,245
1,2457211,8161,6041,5631,5631,4171,5841,4011,3651,3701,2211,004259135905900000
       Other Current Liabilities 
46
59
60
69
6,581
91
98
3,109
2,306
2,774
3,418
-1,500
-3,853
-860
-2,741
8,679
-4,622
-6,471
-8,934
7,440
5,280
5,2807,440-8,934-6,471-4,6228,679-2,741-860-3,853-1,5003,4182,7742,3063,10998916,58169605946
   > Long-term Liabilities 
0
0
0
0
0
0
0
8,338
16,629
16,963
14,980
20,396
21,436
21,949
22,893
23,358
23,358
30,397
30,290
19,773
17,251
17,25119,77330,29030,39723,35823,35822,89321,94921,43620,39614,98016,96316,6298,3380000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
2,180
2,180
0
0
13,550
0
0
0
12,352
14,932
0
0
0
00014,93212,35200013,550002,1802,18000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
208
0
0
0
0
0
0
0
0
0
0
00000000002080000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
64
254
296
5,559
496
7,017
7,860
509
0
10,465
0
0
0
00010,46505097,8607,0174965,5592962546400000000
       Deferred Long Term Liability 
0
0
0
0
0
0
935
0
64
254
296
0
0
0
0
0
0
0
0
0
0
0000000000296254640935000000
> Total Stockholder Equity
-42
-51
-60
-68
0
-89
-107
3,124
-994
-4,692
-7,164
23,684
18,176
11,167
6,451
1,466
1,466
3,989
734
23,321
17,779
17,77923,3217343,9891,4661,4666,45111,16718,17623,684-7,164-4,692-9943,124-107-890-68-60-51-42
   Common Stock
1
1
1
1
0
1
1
3
3
3
3
4
4
4
4
4
4
4
4
5
5
554444444433331101111
   Retained Earnings -151,461-144,962-140,470-136,063-125,791-125,791-120,192-115,112-107,665-101,729-96,278-93,419-88,782-83,878-108-89-75,972-69-61-52-43
   Capital Surplus 
0
0
0
0
0
0
0
0
87,834
88,773
89,157
0
125,916
0
0
0
127,693
140,819
0
0
0
000140,819127,693000125,916089,15788,77387,83400000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
-53
-53
-108
3,173
87,834
88,773
89,157
125,479
125,916
126,485
126,966
-440
127,693
140,819
142,077
169,197
170,141
170,141169,197142,077140,819127,693-440126,966126,485125,916125,47989,15788,77387,8343,173-108-53-530000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue44,855
Cost of Revenue-23,329
Gross Profit21,52621,526
 
Operating Income (+$)
Gross Profit21,526
Operating Expense-40,305
Operating Income-18,779-18,779
 
Operating Expense (+$)
Research Development11,176
Selling General Administrative18,442
Selling And Marketing Expenses10,687
Operating Expense40,30540,305
 
Net Interest Income (+$)
Interest Income903
Interest Expense-2,253
Other Finance Cost-272
Net Interest Income-1,078
 
Pretax Income (+$)
Operating Income-18,779
Net Interest Income-1,078
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19,026-18,532
EBIT - interestExpense = -21,032
-19,026
-16,918
Interest Expense2,253
Earnings Before Interest and Taxes (EBIT)-18,779-16,773
Earnings Before Interest and Taxes (EBITDA)-17,681
 
After tax Income (+$)
Income Before Tax-19,026
Tax Provision-239
Net Income From Continuing Ops-20,278-19,265
Net Income-19,171
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses63,634
Total Other Income/Expenses Net-2471,078
 

Technical Analysis of Augmedix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Augmedix. The general trend of Augmedix is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Augmedix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Augmedix Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.9855 < 1.01 < 1.34.

The bearish price targets are: 0.73.

Tweet this
Augmedix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Augmedix Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Augmedix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Augmedix Inc. The current macd is -0.29914484.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Augmedix price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Augmedix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Augmedix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Augmedix Inc Daily Moving Average Convergence/Divergence (MACD) ChartAugmedix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Augmedix Inc. The current adx is 73.28.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Augmedix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Augmedix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Augmedix Inc. The current sar is 0.90034466.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Augmedix Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Augmedix Inc. The current rsi is 23.33. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Augmedix Inc Daily Relative Strength Index (RSI) ChartAugmedix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Augmedix Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Augmedix price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Augmedix Inc Daily Stochastic Oscillator ChartAugmedix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Augmedix Inc. The current cci is -62.43005058.

Augmedix Inc Daily Commodity Channel Index (CCI) ChartAugmedix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Augmedix Inc. The current cmo is -43.0516432.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Augmedix Inc Daily Chande Momentum Oscillator (CMO) ChartAugmedix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Augmedix Inc. The current willr is -65.65420561.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Augmedix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Augmedix Inc Daily Williams %R ChartAugmedix Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of Augmedix Inc.

Augmedix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Augmedix Inc. The current atr is 0.10112539.

Augmedix Inc Daily Average True Range (ATR) ChartAugmedix Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Augmedix Inc. The current obv is 18,511,600.

Augmedix Inc Daily On-Balance Volume (OBV) ChartAugmedix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Augmedix Inc. The current mfi is 31.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Augmedix Inc Daily Money Flow Index (MFI) ChartAugmedix Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Augmedix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-05-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-05-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Augmedix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Augmedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.328
Ma 20Greater thanMa 500.897
Ma 50Greater thanMa 1001.865
Ma 100Greater thanMa 2003.010
OpenGreater thanClose0.790
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Augmedix with someone you think should read this too:
  • Are you bullish or bearish on Augmedix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Augmedix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Augmedix Inc

I send you an email if I find something interesting about Augmedix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Augmedix Inc.

Receive notifications about Augmedix Inc in your mailbox!